Gedela Srinubabu | |
---|---|
![]() Gedela Srinubabu in 2019, Indian Delegation to Europe | |
Born | Allena, Srikakulam, India |
Alma mater | B.Pharma, MTech, PhD at Andhra University, and Post Doctorate at Stanford University |
Occupation(s) | Scientist, industrialist |
Employer(s) | CEO, OMICS Publishing Group |
Title | Vice-President of Federation of Asian Biotech Association (FABA) and trade delegation of India to the European Union[1][2] |
Website | www |
Gedela Srinubabu is an Indian businessman, scientist and politician. He is the founder and chief executive officer of the OMICS Publishing Group, a scientific journal publishing company that publishes science findings online for free,[3] and CEO of one of its subsidiary companies, Pulsus Group.
Srinubabu was the co-convenor of the Health, Pharma, and Tech Summit Series, executed across G20 countries to promote AI in healthcare and technology advancements. He is also an executive council member of Dr. B. R. Ambedkar University, Srikakulam.
OMICS' journals and conferences have been characterized as predatory publishing journals and predatory conferences with poor quality controls and a lack of legitimate services.[4][5][6] As a result of this business model, Srinubabu's journals have been banned from indexing within the National Institutes of Health's PubMed Central.[7] Additionally, in 2019, his company OMICS Publishing Group[8] was required to pay 50.1 million dollars in damages[9] following a US Federal Trade Commission complaint that the company was deceiving researchers[10] and the academicians.[11][12]
FABA
was invoked but never defined (see the help page).EuropeD2
was invoked but never defined (see the help page).{{cite news}}
: CS1 maint: bot: original URL status unknown (link)